Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 0.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.85 | 1.46 |
NAV | ₹13.61 | ₹692.34 |
Fund Started | 11 Jan 2023 | 07 Oct 2002 |
Fund Size | ₹3664.46 Cr | ₹50648.49 Cr |
Exit Load | Exit load of 1%, if redeemed within 365 days. | Exit Load for units in excess of 30% of the investment,1% will be charged for redemption within 365 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 21.25% | 23.22% |
3 Year | - | 18.01% |
5 Year | - | 20.51% |
1 Year
3 Year
5 Year
Equity | 61.32% | 48.82% |
Cash | 25.24% | 36.35% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 4.42% |
Reliance Industries Ltd. | 3.64% |
Infosys Ltd. | 2.96% |
ICICI Bank Ltd. | 2.81% |
Bharti Airtel Ltd. | 1.93% |
Kotak Mahindra Bank Ltd. | 1.88% |
Larsen & Toubro Ltd. | 1.77% |
NTPC Ltd. | 1.76% |
Mahindra & Mahindra Ltd. | 1.68% |
Coforge Ltd. | 1.64% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 4.76% |
HDFC Bank Ltd. | 4.45% |
Maruti Suzuki India Ltd. | 3.78% |
NTPC Ltd. | 3.11% |
Reliance Industries Ltd. | 2.94% |
Bajaj Finserv Ltd. | 2.40% |
SBI Cards And Payment Services Ltd. | 2.15% |
Infosys Ltd. | 1.98% |
Larsen & Toubro Ltd. | 1.89% |
Sun Pharmaceutical Industries Ltd. | 1.72% |
Name | Dhaval Joshi | Sri Sharma |
Start Date | 21 Nov 2022 | 30 Apr 2021 |
Name
Start Date
Description | The Scheme seeks to provide long term capital appreciation by investing across asset classes like Equity, Debt, Commodities, & units of REITs & InvITs. | The scheme seeks to generate capital appreciation for investors by investing predominantly in equity and equity related instruments and income by investing across other asset classes. |
Launch Date | 11 Jan 2023 | 07 Oct 2002 |
Description
Launch Date